相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Outcomes associated with different vaccines in individuals with bipolar disorder and impact on the current COVID-19 pandemic- a systematic review
Eva Z. Reininghaus et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Letter to the editor about the article Psychiatric disorders in post-acute COVID-syndrome 3 (PDPACS): Recommendations for health care professionals (Falconi A et al., 2022)
Cristian-Daniel Llach et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)
Can selective serotonin reuptake inhibitors/serotonin and norepinephrine reuptake inhibitor antidepressants decrease the cytokine storm in the course of COVID-19 pneumonia?
Leonardo Fei et al.
PANMINERVA MEDICA (2022)
RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19
Yi Jiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Increased risk ofCOVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
QuanQiu Wang et al.
WORLD PSYCHIATRY (2021)
Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review
Kawthar Mohamed et al.
BIOORGANIC CHEMISTRY (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
Brenda T. Pun et al.
LANCET RESPIRATORY MEDICINE (2021)
COMPARE Analysis, a Bioinformatic Approach to Accelerate Drug Repurposing against Covid-19 and Other Emerging Epidemics
Imad Naasani
SLAS DISCOVERY (2021)
Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study
Paul M. McKeigue et al.
BMC MEDICINE (2021)
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
Jiayu Lu et al.
LIFE SCIENCES (2021)
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study
Nicolas Hoertel et al.
MOLECULAR PSYCHIATRY (2021)
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population
M. Canal-Rivero et al.
SCHIZOPHRENIA RESEARCH (2021)
The outcomes of patients with diabetes mellitus in The Philippine CORONA Study
Adrian Espiritu et al.
SCIENTIFIC REPORTS (2021)
Mental disorders, psychopharmacological treatments, and mortality in 2150 COVID-19 Spanish inpatients
Crisanto Diez-Quevedo et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
Sebastian Schloer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness
Katlyn Nemani et al.
JAMA PSYCHIATRY (2021)
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19
Joshua L. Denson et al.
JAMA NETWORK OPEN (2021)
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants
Tomiko Oskotsky et al.
JAMA NETWORK OPEN (2021)
Associations between COVID-19 and 30-day thromboembolic events and mortality in people with dementia receiving antipsychotic medications
Stephanie L. Harrison et al.
PHARMACOLOGICAL RESEARCH (2021)
MOOSE Reporting Guidelines for Meta-analyses of Observational Studies
Benjamin S. Brooke et al.
JAMA SURGERY (2021)
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
Vikas P. Sukhatme et al.
FRONTIERS IN PHARMACOLOGY (2021)
Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
Sherry H. -Y. Chou et al.
JAMA NETWORK OPEN (2021)
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Justin Fortune Creeden et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay
Jennifer Loschwitz et al.
BIOORGANIC CHEMISTRY (2021)
Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection
Cristian-Daniel Llach et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection
Shaymaa Elsayed Khater et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In Vitro
Linda Brunotte et al.
PHARMACEUTICS (2021)
Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action
Lin Liu et al.
ECLINICALMEDICINE (2021)
Are dopamine and serotonin involved in COVID-19 pathophysiology?
L. Attademo et al.
EUROPEAN JOURNAL OF PSYCHIATRY (2021)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Repurposing chlorpromazine to treat COVID-19: The reCoVery study
M. Plaze et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Lithium's antiviral effects: a potential drug for CoViD-19 disease?
Andrea Murru et al.
INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2020)
Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
Tania Viel et al.
AGING-US (2020)
Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain
Beatriz Poblador-Plou et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
COVID-19 inpatients with psychiatric disorders: Real-world clinical recommendations from an expert team in consultation-liaison psychiatry
G. Anmella et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis
Preeti Pandey et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Laser irradiated phenothiazines: New potential treatment for COVID-19 explored by molecular docking
Ana-Maria Udrea et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2020)
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial
Eric J. Lenze et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Cytokine Storm
David C. Fajgenbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches
Giovanni Ostuzzi et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine
Sebastian Schloer et al.
EMERGING MICROBES & INFECTIONS (2020)
Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis
Dorian A. Rosen et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration
Nathalie Cloutier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Proliferation and apoptosis of T lymphocytes in patients with bipolar disorder
Krzysztof Pietruczuk et al.
SCIENTIFIC REPORTS (2018)
The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis
Yangyu Zhang et al.
BMC PSYCHIATRY (2017)
Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
David Baumeister et al.
PSYCHOPHARMACOLOGY (2016)
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Arthur Kavanaugh
Therapeutics and Clinical Risk Management (2016)
Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
Vitor Caiaffo et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2016)
Inflammation: its role in schizophrenia and the potential anti-inflammatory effects of antipsychotics
Valeria Mondelli et al.
PSYCHOPHARMACOLOGY (2014)
Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review
Raul Herzog et al.
BMC PUBLIC HEALTH (2013)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)